Galena Biopharma Company Profile (NASDAQ:GALE)

About Galena Biopharma

Galena Biopharma logoGalena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system to seek out and attack any residual cancer cells.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GALE
  • CUSIP:
Key Metrics:
  • Previous Close: $0.42
  • 50 Day Moving Average: $0.4389
  • 200 Day Moving Average: $1.1147
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.23
  • P/E Growth: 0.0000
  • Market Cap: $89.91M
  • Outstanding Shares: 213,968,000
  • Beta: 1.93
Additional Links:
Companies Related to Galena Biopharma:

Analyst Ratings

Consensus Ratings for Galena Biopharma (NASDAQ:GALE) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $2.63 (524.70% upside)

Analysts' Ratings History for Galena Biopharma (NASDAQ:GALE)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016FBR & CoReiterated RatingOutperform$2.00View Rating Details
8/10/2016Maxim GroupLower Price TargetBuy$2.00 -> $1.00View Rating Details
7/1/2016S&P Equity ResearchLower Price Target$0.61 -> $0.50View Rating Details
6/29/2016Noble FinancialDowngradeBuy -> HoldView Rating Details
6/29/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
6/9/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details
1/22/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$4.00View Rating Details
12/8/2015Cantor FitzgeraldUpgradeSell -> Hold$2.00View Rating Details
8/7/2015MLV & Co.Reiterated RatingBuy$5.00View Rating Details
3/6/2015Needham & Company LLCSet Price TargetBuy$7.00 -> $4.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Galena Biopharma (NASDAQ:GALE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.06)$0.05ViewN/AView Earnings Details
5/10/2016Q1($0.06)($0.07)ViewListenView Earnings Details
3/10/2016Q4($0.05)($0.07)$2.61 millionViewListenView Earnings Details
11/9/2015Q315($0.07)($0.11)$4.22 millionViewListenView Earnings Details
8/6/2015Q215($0.09)($0.10)$3.54 million$3.38 millionViewN/AView Earnings Details
5/7/2015Q115($0.09)($0.08)$3.47 million$2.75 millionViewListenView Earnings Details
3/5/2015Q414($0.11)($0.06)$2.58 million$3.20 millionViewN/AView Earnings Details
11/3/2014Q314($0.11)($0.05)$2.66 million$1.60 millionViewN/AView Earnings Details
8/11/2014Q214($0.09)($0.17)$2.99 million$2.30 millionViewN/AView Earnings Details
5/6/2014Q1($0.10)($0.02)$2.09 million$2.17 millionViewN/AView Earnings Details
3/17/2014Q413($0.09)($0.46)$1.62 million$1.32 millionViewN/AView Earnings Details
8/8/2013Q213($0.10)($0.11)ViewN/AView Earnings Details
3/12/2013Q4 2012($0.62)($0.53)ViewN/AView Earnings Details
11/13/2012Q312($0.09)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Galena Biopharma (NASDAQ:GALE)
Current Year EPS Consensus Estimate: $-0.1200 EPS
Next Year EPS Consensus Estimate: $-0.1300 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.05)($0.05)($0.05)
Q2 20161($0.08)($0.08)($0.08)
Q3 20161($0.04)($0.04)($0.04)
Q4 20162($0.06)($0.03)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Galena Biopharma (NASDAQ:GALE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Galena Biopharma (NASDAQ:GALE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/12/2014Richard ChinDirectorSell187,500$4.33$811,875.00View SEC Filing  
2/7/2014Rudolph NisiDirectorBuy20,000$4.94$98,800.00View SEC Filing  
1/30/2014Mark SchwartzCOOSell100,000$5.57$557,000.00View SEC Filing  
1/30/2014Sanford HillsbergDirectorSell250,000$5.41$1,352,500.00View SEC Filing  
1/29/2014Rudolph NisiDirectorSell250,000$5.28$1,320,000.00View SEC Filing  
1/22/2014Steven KriegsmanDirectorSell450,000$6.52$2,934,000.00View SEC Filing  
1/17/2014Rudolph NisiDirectorSell200,000$6.90$1,380,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Galena Biopharma (NASDAQ:GALE)
DateHeadline
News IconTrading the Biotech News: Stemline Therapeutics, Inc. (NASDAQ:STML), Galena Biopharma, Inc. (NASDAQ:GALE) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - August 26 at 8:06 AM
4-traders.com logoStocks in Spotlight: Galena Biopharma, Inc. Amsurg Corp. (NASDAQ:GALE)
www.4-traders.com - August 23 at 5:18 PM
biz.yahoo.com logoGALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right (NASDAQ:GALE)
biz.yahoo.com - August 23 at 5:18 PM
News IconNotable Movers: Sophiris Bio Inc (NASDAQ:SPHS), Galena Biopharma Inc (NASDAQ:GALE) - Post Registrar (NASDAQ:GALE)
postregistrar.com - August 22 at 5:12 PM
biz.yahoo.com logoGALENA BIOPHARMA, INC. Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:GALE)
biz.yahoo.com - August 22 at 5:12 PM
News IconStock Tracking Lower for the Quarter: Galena Biopharma, Inc. (NASDAQ:GALE) - Post News (NASDAQ:GALE)
www.kentuckypostnews.com - August 20 at 5:02 PM
finance.yahoo.com logoGalena Biopharma (GALE) is Oversold: Can It Recover? (NASDAQ:GALE)
finance.yahoo.com - August 19 at 5:03 PM
finance.yahoo.com logoGALENA BIOPHARMA, INC. Financials (NASDAQ:GALE)
finance.yahoo.com - August 19 at 5:03 PM
4-traders.com logoGALENA BIOPHARMA, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:GALE)
www.4-traders.com - August 18 at 5:09 PM
smarteranalyst.com logoFBR Analyst Stays Bullish on Galena Biopharma Inc (GALE) Following 2Q:16 Update (NASDAQ:GALE)
www.smarteranalyst.com - August 18 at 5:09 PM
smarteranalyst.com logoFBR Analyst Stays Bullish on Galena Biopharma Inc (GALE) Following 2Q:16 Update - Smarter Analyst (NASDAQ:GALE)
www.smarteranalyst.com - August 17 at 5:23 PM
News IconBiotechnology Stocks Grabbing Investor's Attention: Galena Biopharma Inc (NASDAQ:GALE), Celgene Corporation ... - Post Registrar (NASDAQ:GALE)
postregistrar.com - August 16 at 5:17 PM
biz.yahoo.com logoGALENA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan (NASDAQ:GALE)
biz.yahoo.com - August 16 at 5:17 PM
News IconGalena Biopharma Inc. (GALE) Issues Earnings Results (NASDAQ:GALE)
myhealthbowl.com - August 16 at 8:29 AM
istreetwire.com logoTrader Alert: HollyFrontier Corporation (HFC), Galena Biopharma, Inc. (GALE), Mast Therapeutics, Inc. (MSTX) - iStreetWire (NASDAQ:GALE)
istreetwire.com - August 15 at 12:08 PM
reuters.com logoBRIEF-Galena Biopharma says amended Nov 2014 purchase agreement with Lincoln Park Capital (NASDAQ:GALE)
www.reuters.com - August 13 at 8:04 AM
smarteranalyst.com logoMaxim Slashes Price Target on Galena Biopharma Inc (GALE) Following 2Q:16 Update (NASDAQ:GALE)
www.smarteranalyst.com - August 12 at 5:12 PM
biz.yahoo.com logoGALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:GALE)
biz.yahoo.com - August 12 at 5:12 PM
smarteranalyst.com logoMaxim Slashes Price Target on Galena Biopharma Inc (GALE) Following 2Q:16 Update - Smarter Analyst (NASDAQ:GALE)
www.smarteranalyst.com - August 12 at 8:09 AM
globenewswire.com logoGalena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update (NASDAQ:GALE)
globenewswire.com - August 11 at 5:22 PM
smarteranalyst.com logoStock Update (NASDAQ:GALE): Galena Biopharma Inc Reports Second Quarter 2016 Financial Results and Provides a Corporate Update (NASDAQ:GALE)
www.smarteranalyst.com - August 11 at 5:22 PM
News IconWill Galena Biopharma Inc (NASDAQ:GALE) Beat Earnings Estimates? (NASDAQ:GALE)
potiner.com - August 11 at 5:22 PM
News IconGalena Biopharma Inc (NASDAQ:GALE) & Fossil Group Inc (NASDAQ:FOSL) Hot Stock's Alert - Money News (press release) (NASDAQ:GALE)
www.newsismoney.com - August 10 at 12:35 PM
finance.yahoo.com logoEdited Transcript of GALE earnings conference call or presentation 9-Aug-16 9:00pm GMT (NASDAQ:GALE)
finance.yahoo.com - August 10 at 12:35 PM
News IconBiotech Stocks To Put On Your Watch List: Galena Biopharma, Inc. (NASDAQ:GALE), Ariad Pharmaceuticals Inc ... - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - August 9 at 9:30 PM
sg.finance.yahoo.com logoGalena Biopharma beats 2Q profit forecasts (NASDAQ:GALE)
sg.finance.yahoo.com - August 9 at 9:30 PM
nasdaq.com logoEarnings Reaction History: Galena Biopharma, Inc., 66.7% Follow-Through Indicator, 6.4% Sensitive - Nasdaq (NASDAQ:GALE)
www.nasdaq.com - August 9 at 3:53 PM
News IconHealthcare Stocks Flagged As Top Movers: Galena Biopharma, Inc. (NASDAQ:GALE), Brookdale Senior Living Inc ... - TWN (NASDAQ:GALE)
thewellesleysnews.com - August 9 at 8:04 AM
biz.yahoo.com logoQ2 2016 Galena Biopharma Inc Earnings Release - After Market Close (NASDAQ:GALE)
biz.yahoo.com - August 9 at 8:04 AM
streetupdates.com logoAnalysts Observing Stocks: Galena Biopharma, Inc. (NASDAQ:GALE) , Humana Inc. (NYSE:HUM) - Street Updates (NASDAQ:GALE)
www.streetupdates.com - August 8 at 9:54 AM
News IconHC Stocks Indications: Galena Biopharma Inc (NASDAQ:GALE) Pernix Therapeutics Holdings Inc (NASDAQ:PTX) - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - August 8 at 9:54 AM
News IconAnalyst Research Roundup: Galena Biopharma, Inc. (NASDAQ:GALE), SLM Corporation (NASDAQ:SLM) - TWN (NASDAQ:GALE)
thewellesleysnews.com - August 6 at 8:00 AM
News IconHC Stocks in Drift: Galena Biopharma Inc (NASDAQ:GALE), Pfizer ... - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - August 6 at 8:00 AM
equities.com logoGalena Biopharma Inc. (GALE) Jumps 5.56% on August 05 - Equities.com (NASDAQ:GALE)
www.equities.com - August 6 at 8:00 AM
streetupdates.com logoHave a look at Analyst Actions: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Galena Biopharma, Inc. (NASDAQ:GALE) - Street Updates (NASDAQ:GALE)
www.streetupdates.com - August 5 at 8:02 AM
equities.com logoGalena Biopharma Inc. (GALE) Jumps 7.08% on August 03 - Equities.com (NASDAQ:GALE)
www.equities.com - August 5 at 8:02 AM
streetupdates.com logoStocks within Analysts Spotlight: Galena Biopharma, Inc. (NASDAQ ... - Street Updates (NASDAQ:GALE)
www.streetupdates.com - August 4 at 5:29 PM
fortune.com logoThe Insider Activity Don't Lie: Galena Biopharma, Inc. (NASDAQ ... - Review Fortune (NASDAQ:GALE)
reviewfortune.com - August 3 at 8:04 AM
streetupdates.com logoTwo Stocks within Analysts Limelight: Galena Biopharma, Inc. (NASDAQ:GALE) , XOMA Corporation (NASDAQ:XOMA) - Street Updates (NASDAQ:GALE)
www.streetupdates.com - August 2 at 5:25 PM
fortune.com logoAnalyst Ratings On Watch List: Galena Biopharma Inc (NASDAQ:GALE), Raven Industries, Inc. (NASDAQ:RAVN) - Review Fortune (NASDAQ:GALE)
reviewfortune.com - August 1 at 5:03 PM
News IconHC Stocks Indications: Galena Biopharma Inc (NASDAQ:GALE) Bristol-Myers Squibb Co (NYSE:BMY) - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - August 1 at 9:55 AM
fortune.com logoGalena Biopharma, Inc. (NASDAQ:GALE): Updated Analyst Ratings - Review Fortune (NASDAQ:GALE)
reviewfortune.com - July 30 at 4:44 PM
News IconHC Stocks Highlights: Galena Biopharma Inc (NASDAQ:GALE), Pfizer Inc. (NYSE:PFE) - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - July 30 at 8:01 AM
fortune.com logoStocks Worth Mentioning Ratings-Wise: Unisys Corporation (NYSE:UIS), Galena Biopharma Inc (NASDAQ:GALE) - Review Fortune (NASDAQ:GALE)
reviewfortune.com - July 28 at 3:55 PM
News IconEarnings in Focus: Galena Biopharma, Inc. (NASDAQ:GALE), The ... - News Oracle (NASDAQ:GALE)
www.newsoracle.com - July 28 at 3:55 PM
ftsenews.co.uk logoNew Broker Ratings For Galena Biopharma, Inc. (GALE) - FTSE ... - FTSE News (NASDAQ:GALE)
www.ftsenews.co.uk - July 28 at 3:55 PM
News IconActive biotech company shares in the news: Galena Biopharma, Inc. (NASDAQ:GALE), Celgene Corporation (NASDAQ ... - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - July 28 at 5:02 AM
nasdaq.com logoGalena Biopharma to Report Second Quarter 2016 Financial Results and Provide a Corporate Update on (NASDAQ:GALE)
www.nasdaq.com - July 26 at 11:20 PM
News IconStock under Analyst' Radar: Galena Biopharma, Inc. (NASDAQ:GALE) - News Oracle (NASDAQ:GALE)
www.newsoracle.com - July 26 at 5:17 PM
streetupdates.com logoRecent Analysts Ratings Fluctuations: Galena Biopharma, Inc ... - Street Updates (NASDAQ:GALE)
www.streetupdates.com - July 26 at 5:17 PM

Social

Galena Biopharma (NASDAQ:GALE) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff